Global Parkinsons Disease Drugs Industry Research Report 2020, Forecast to 2025

June 2020 | 105 pages | ID: G42689A75262EN
WKinformation

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

The Parkinsons Disease Drugs market was valued at US$ xx in 2019, prior to COVID-19. Whereas post-COVID-19 scenario, the market for Parkinsons Disease Drugs is projected to grow from US$ xx million in 2020, and is projected to reach xx by 2025, at a CAGR of xx% during the forecast period. Projected and forecast revenue values are in constant U.S. dollars, unadjusted for inflation. Product values are estimated based on manufacturers' revenue.

The report offers detailed coverage of Parkinsons Disease Drugs industry and main market trends. The market research includes historical and forecast market data, demand, application details, price trends, and company shares of the leading Parkinsons Disease Drugs by geography. The report splits the market size, by volume and value, on the basis of application type and geography.

In addition to this data, the report provides insight into drivers of market demand and strategies of suppliers. Key players are profiled, and their market shares in the global Parkinsons Disease Drugs market are discussed.

The market is segmented by types:

• Clinical
• Experiment

It can be also divided by applications:

• Treament
• Prevention

And this report covers the historical situation, present status and the future prospects of the global Parkinsons Disease Drugs market for 2015-2025. In this report, we analyze global market from 5 geographies: Asia-Pacific, Europe, North America, Middle East & Africa, South America.

Finally, the report provides detailed profile and data information analysis of leading company.

• Johnson & Johnson
• Teva Pharmaceutical
• Sun Pharmaceutical
• Gilead Sciences
• Fudan-Zhangjiang
• Pacira
• Novartis
• Sigma-Tau Group
• Luye Pharma
• CSPC
• Kingond Pharm

Report Includes:

• xx data tables and xx additional tables
• An overview of global Parkinsons Disease Drugs market
• An detailed key players analysis across regions
• Analyses of global market trends, with historical data, estimates for 2020 and projections of compound annual growth rates (CAGRs) through 2025
• Insights into regulatory and environmental developments
• Information on the supply and demand scenario and evaluation of technological and investment opportunities in the Parkinsons Disease Drugs market
• Profiles of major players in the industry, including Johnson & Johnson, Teva Pharmaceutical, Sun Pharmaceutical, Gilead Sciences, Fudan-Zhangjiang.....

Research objectives

• To study and analyze the global Parkinsons Disease Drugs consumption (value & volume) by key regions/countries, product type and application, history data from 2015 to 2019, and forecast to 2025.
• To understand the structure of Parkinsons Disease Drugs market by identifying its various subsegments.
• Focuses on the key global Parkinsons Disease Drugs manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, Porter's five forces analysis, SWOT analysis and development plans in next few years.
• To analyze the Parkinsons Disease Drugs with respect to individual growth trends, future prospects, and their contribution to the total market.
• To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
• To project the consumption of Parkinsons Disease Drugs submarkets, with respect to key regions (along with their respective key countries).
• To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
• To strategically profile the key players and comprehensively analyze their growth strategies.

Contents

Global Parkinsons Disease Drugs Market Report 2020, Forecast to 2025

1 SCOPE OF THE STUDY

1.1 Parkinsons Disease Drugs Introduction
1.2 Research Programs
1.3 Analysis of Macroeconomic Indicators
1.4 Years Considered
1.5 Methodology
1.6 Data Source
1.7 Research Objectives

2 PARKINSONS DISEASE DRUGS INDUSTRY OVERVIEW

2.1 Global Parkinsons Disease Drugs Market Size (Million USD) Comparison by Regions (2020-2025)
  2.1.1 Parkinsons Disease Drugs Global Import Market Analysis
  2.1.2 Parkinsons Disease Drugs Global Export Market Analysis
  2.1.3 Parkinsons Disease Drugs Global Main Region Market Analysis
2.2 Market Analysis by Type
  2.2.1 Clinical
  2.2.2 Experiment
2.3 Market Analysis by Application
  2.3.1 Treament
  2.3.2 Prevention
2.4 Global Parkinsons Disease Drugs Revenue, Sales and Market Share by Manufacturer
  2.4.1 Global Parkinsons Disease Drugs Sales and Market Share by Manufacturer (2018-2020)
  2.4.2 Global Parkinsons Disease Drugs Revenue and Market Share by Manufacturer (2018-2020)
  2.4.3 Global Parkinsons Disease Drugs Industry Concentration Ratio (CR5 and HHI)
  2.4.4 Top 5 Parkinsons Disease Drugs Manufacturer Market Share
  2.4.5 Top 10 Parkinsons Disease Drugs Manufacturer Market Share
  2.4.6 Date of Key Manufacturers Enter into Parkinsons Disease Drugs Market
  2.4.7 Key Manufacturers Parkinsons Disease Drugs Product Offered
  2.4.8 Mergers & Acquisitions Planning
2.5 Parkinsons Disease Drugs Historical Development Overview
2.6 Market Dynamics
  2.6.1 Market Opportunities
  2.6.2 Market Risk
  2.6.3 Market Driving Force
  2.6.4 Porter's Five Forces Analysis
2.7 Coronavirus Disease 2019 (Covid-19): Parkinsons Disease Drugs Industry Impact
  2.7.1 How the Covid-19 is Affecting the Parkinsons Disease Drugs Industry
  2.7.2 Parkinsons Disease Drugs Business Impact Assessment - Covid-19
  2.7.3 Market Trends and Parkinsons Disease Drugs Potential Opportunities in the COVID-19 Landscape
  2.7.4 Measures / Proposal against Covid-19

3 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS

3.1 Upstream Analysis
  3.1.1 Macro Analysis of Upstream Markets
  3.1.2 Key Players in Upstream Markets
  3.1.3 Upstream Market Trend Analysis
  3.1.4 Parkinsons Disease Drugs Manufacturing Cost Analysis
3.2 Downstream Market Analysis
  3.2.1 Macro Analysis of Down Markets
  3.2.2 Key Players in Down Markets
  3.2.3 Downstream Market Trend Analysis
  3.2.4 Sales Channel, Distributors, Traders and Dealers

4 GLOBAL PARKINSONS DISEASE DRUGS MARKET SIZE CATEGORIZED BY REGIONS (2015-2020)

4.1 Global Parkinsons Disease Drugs Sales Market Share by Region
4.2 Global Parkinsons Disease Drugs Revenue Market Share by Region (2015-2019)
4.3 Global Parkinsons Disease Drugs Sales, Revenue, Price and Gross Margin (2015-2020)
4.4 North America Parkinsons Disease Drugs Market Size Detail
  4.4.1 North America Parkinsons Disease Drugs Sales Growth Rate (2015-2020)
  4.4.2 North America Parkinsons Disease Drugs Sales, Revenue, Price and Gross Margin (2015-2020)
4.5 Europe Parkinsons Disease Drugs Market Size Detail
  4.5.1 Europe Parkinsons Disease Drugs Sales Growth Rate (2015-2020)
  4.5.2 Europe Parkinsons Disease Drugs Sales, Revenue, Price and Gross Margin (2015-2020)
4.6 Japan Parkinsons Disease Drugs Market Size Detail
  4.6.1 Japan Parkinsons Disease Drugs Sales Growth Rate (2015-2020)
  4.6.2 Japan Parkinsons Disease Drugs Sales, Revenue, Price and Gross Margin (2015-2020)
4.7 China Parkinsons Disease Drugs Market Size Detail
  4.7.1 China Parkinsons Disease Drugs Sales Growth Rate (2015-2020)
  4.7.2 China Parkinsons Disease Drugs Sales, Revenue, Price and Gross Margin (2015-2020)

5 GLOBAL PARKINSONS DISEASE DRUGS MARKET SEGMENT BY TYPE

5.1 Global Parkinsons Disease Drugs Revenue, Sales and Market Share by Type (2015-2020)
  5.1.1 Global Parkinsons Disease Drugs Sales and Market Share by Type (2015-2020)
  5.1.2 Global Parkinsons Disease Drugs Revenue and Market Share by Type (2015-2020)
5.2 Clinical Sales Growth Rate and Price
  5.2.1 Global Clinical Sales Growth Rate (2015-2020)
  5.2.2 Global Clinical Price (2015-2020)
5.3 Experiment Sales Growth Rate and Price
  5.3.1 Global Experiment Sales Growth Rate (2015-2020)
  5.3.2 Global Experiment Price (2015-2020)

6 GLOBAL PARKINSONS DISEASE DRUGS MARKET SEGMENT BY APPLICATION

6.1 Global Parkinsons Disease DrugsSales Market Share by Application (2015-2020)
6.2 Treament Sales Growth Rate (2015-2020)
6.3 Prevention Sales Growth Rate (2015-2020)

7 GLOBAL PARKINSONS DISEASE DRUGS MARKET FORECAST

7.1 Global Parkinsons Disease Drugs Sales, Revenue Forecast
  7.1.1 Global Parkinsons Disease Drugs Sales Growth Rate Forecast (2020-2025)
  7.1.2 Global Parkinsons Disease Drugs Revenue and Growth Rate Forecast (2020-2025)
  7.1.3 Global Parkinsons Disease Drugs Price and Trend Forecast (2020-2025)
7.2 Global Parkinsons Disease Drugs Sales Forecast by Region (2020-2025)
  7.2.1 North America Parkinsons Disease Drugs Sales, Revenue Forecast (2020-2025)
  7.2.2 Europe Parkinsons Disease Drugs Sales, Revenue Forecast (2020-2025)
  7.2.3 Japan Parkinsons Disease Drugs Production, Revenue Forecast (2020-2025)
  7.2.4 China Parkinsons Disease Drugs Production, Revenue Forecast (2020-2025)

8 ANALYSIS OF PARKINSONS DISEASE DRUGS INDUSTRY KEY MANUFACTURERS

8.1 Johnson & Johnson
  8.1.1 Company Details
  8.1.2 Product Information
  8.1.3 Johnson & Johnson Parkinsons Disease Drugs Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
  8.1.4 Main Business Overview
  8.1.5 Johnson & Johnson News
8.2 Teva Pharmaceutical
  8.2.1 Company Details
  8.2.2 Product Information
  8.2.3 Teva Pharmaceutical Parkinsons Disease Drugs Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
  8.2.4 Main Business Overview
  8.2.5 Teva Pharmaceutical News
8.3 Sun Pharmaceutical
  8.3.1 Company Details
  8.3.2 Product Information
  8.3.3 Sun Pharmaceutical Parkinsons Disease Drugs Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
  8.3.4 Main Business Overview
  8.3.5 Sun Pharmaceutical News
8.4 Gilead Sciences
  8.4.1 Company Details
  8.4.2 Product Information
  8.4.3 Gilead Sciences Parkinsons Disease Drugs Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
  8.4.4 Main Business Overview
  8.4.5 Gilead Sciences News
8.5 Fudan-Zhangjiang
  8.5.1 Company Details
  8.5.2 Product Information
  8.5.3 Fudan-Zhangjiang Parkinsons Disease Drugs Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
  8.5.4 Main Business Overview
  8.5.5 Fudan-Zhangjiang News
8.6 Pacira
  8.6.1 Company Details
  8.6.2 Product Information
  8.6.3 Pacira Parkinsons Disease Drugs Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
  8.6.4 Main Business Overview
  8.6.5 Pacira News
8.7 Novartis
  8.7.1 Company Details
  8.7.2 Product Information
  8.7.3 Novartis Parkinsons Disease Drugs Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
  8.7.4 Main Business Overview
  8.7.5 Novartis News
8.8 Sigma-Tau Group
  8.8.1 Company Details
  8.8.2 Product Information
  8.8.3 Sigma-Tau Group Parkinsons Disease Drugs Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
  8.8.4 Main Business Overview
  8.8.5 Sigma-Tau Group News
8.9 Luye Pharma
  8.9.1 Company Details
  8.9.2 Product Information
  8.9.3 Luye Pharma Parkinsons Disease Drugs Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
  8.9.4 Main Business Overview
  8.9.5 Luye Pharma News
8.10 CSPC
  8.10.1 Company Details
  8.10.2 Product Information
  8.10.3 CSPC Parkinsons Disease Drugs Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
  8.10.4 Main Business Overview
  8.10.5 CSPC News
8.11 Kingond Pharm
  8.11.1 Company Details
  8.11.2 Product Information
  8.11.3 Kingond Pharm Parkinsons Disease Drugs Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
  8.11.4 Main Business Overview
  8.11.5 Kingond Pharm News

9 RESEARCH FINDINGS AND CONCLUSION

10 APPENDIX

List Of Tables

LIST OF TABLES AND FIGURES

Figure Parkinsons Disease Drugs Picture
Figure Research Programs/Design for This Report
Figure Global Parkinsons Disease Drugs Market by Regions (2019)
Table Global Market Parkinsons Disease Drugs Comparison by Regions (M USD) 2019-2025
Table Global Parkinsons Disease Drugs Sales Growth (CAGR) (2019-2025) by Type
Figure Global Sales Market Share of Parkinsons Disease Drugs by Type in 2019
Figure Clinical Picture
Figure Experiment Picture
Table Global Parkinsons Disease Drugs Sales by Application (2019-2025)
Figure Global Parkinsons Disease Drugs Sales Market Share by Application in 2019
Figure Treament Picture
Figure Prevention Picture
Table Global Parkinsons Disease Drugs Sales by Manufacturer (2018-2020)
Figure Global Parkinsons Disease Drugs Sales Market Share by Manufacturer in 2019
Table Global Parkinsons Disease Drugs Revenue by Manufacturer (2018-2020)
Figure Global Parkinsons Disease Drugs Revenue Market Share by Manufacturer in 2019
Table Global Parkinsons Disease Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Figure Top 5 Parkinsons Disease Drugs Manufacturer (Revenue) Market Share in 2019
Figure Top 10 Parkinsons Disease Drugs Manufacturer (Revenue) Market Share in 2019
Table Date of Key Manufacturers Enter into Parkinsons Disease Drugs Market
Table Key Manufacturers Parkinsons Disease Drugs Product Type
Table Mergers & Acquisitions Planning
Table Market Opportunities in Next Few Years
Table Market Risks Analysis
Table Market Drivers
Table Key Players of Upstream Markets
Table Key Raw Materials
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Parkinsons Disease Drugs
Table Key Players of Upstream Markets
Figure Sales Channel
Table Global Parkinsons Disease Drugs Sales (K Units) by Region (2015-2020)
Table Global Parkinsons Disease Drugs Sales Market Share by Region (2015-2019)
Figure Global Parkinsons Disease Drugs Sales Market Share by Region (2015-2019)
Figure Global Parkinsons Disease Drugs Sales Market Share by Region in 2018
Table Global Parkinsons Disease Drugs Revenue (Million US$) by Region (2015-2020)
Table Global Parkinsons Disease Drugs Revenue Market Share by Region (2015-2020)
Figure Global Parkinsons Disease Drugs Revenue Market Share by Region (2015-2020)
Figure Global Parkinsons Disease Drugs Revenue Market Share by Region in 2019
Table Global Parkinsons Disease Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Figure North America Parkinsons Disease Drugs Sales (K Units) Growth Rate (2015-2020)
Table North America Parkinsons Disease Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Figure Europe Parkinsons Disease Drugs Sales (K Units) Growth Rate (2015-2020)
Table Europe Parkinsons Disease Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Figure Japan Parkinsons Disease Drugs Sales (K Units) Growth Rate (2015-2020)
Table Japan Parkinsons Disease Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Figure China Parkinsons Disease Drugs Sales (K Units) Growth Rate (2015-2020)
Table China Parkinsons Disease Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table Global Parkinsons Disease Drugs Sales by Type (2015-2020)
Table Global Parkinsons Disease Drugs Sales Market Share by Type (2015-2020)
Figure Global Parkinsons Disease Drugs Sales Market Share by Type in 2019
Table Global Parkinsons Disease Drugs Revenue by Type (2015-2020)
Table Global Parkinsons Disease Drugs Revenue Market Share by Type (2015-2020)
Figure Global Parkinsons Disease Drugs Revenue Market Share by Type in 2019
Figure Global Clinical Sales Growth Rate (2015-2020)
Figure Global Clinical Price (2015-2020)
Figure Global Experiment Sales Growth Rate (2015-2020)
Figure Global Experiment Price (2015-2020)
Table Global Parkinsons Disease Drugs Sales by Application (2015-2020)
Table Global Parkinsons Disease Drugs Sales Market Share by Application (2015-2020)
Figure Global Parkinsons Disease Drugs Sales Market Share by Application in 2019
Figure Global Treament Sales Growth Rate (2015-2020)
Figure Global Prevention Sales Growth Rate (2015-2020)
Figure Global Parkinsons Disease Drugs Production (K Units) Growth Rate Forecast (2020-2025)
Figure Global Parkinsons Disease Drugs Revenue (Million US$) Growth Rate Forecast (2020-2025)
Figure Global Parkinsons Disease Drugs Price and Trend Forecast (2020-2025)
Table Global Parkinsons Disease Drugs Sales (K Units) Forecast by Region (2020-2025)
Figure Global Parkinsons Disease Drugs Production Market Share Forecast by Region (2020-2025)
Figure North America Parkinsons Disease Drugs Sales (K Units) Growth Rate Forecast (2020-2025)
Figure North America Parkinsons Disease Drugs Revenue (Million US$) Growth Rate Forecast (2020-2025)
Figure Europe Parkinsons Disease Drugs Sales (K Units) Growth Rate Forecast (2020-2025)
Figure Europe Parkinsons Disease Drugs Revenue (Million US$) Growth Rate Forecast (2020-2025)
Figure Japan Parkinsons Disease Drugs Production (K Units) Growth Rate Forecast (2020-2025)
Figure Japan Parkinsons Disease Drugs Revenue (Million US$) Growth Rate Forecast (2020-2025)
Figure China Parkinsons Disease Drugs Production (K Units) Growth Rate Forecast (2020-2025)
Figure China Parkinsons Disease Drugs Revenue (Million US$) Growth Rate Forecast (2020-2025)
Table Johnson & Johnson Company Profile
Figure Parkinsons Disease Drugs Product Picture and Specifications of Johnson & Johnson
Table Parkinsons Disease Drugs Production, Price, Revenue and Gross Margin of 2018-2020
Figure Johnson & Johnson Parkinsons Disease Drugs Market Share (2018-2020)
Table Johnson & Johnson Main Business
Table Johnson & Johnson Recent Development
Table Teva Pharmaceutical Company Profile
Figure Parkinsons Disease Drugs Product Picture and Specifications of Teva Pharmaceutical
Table Parkinsons Disease Drugs Production, Price, Revenue and Gross Margin of 2018-2020
Figure Teva Pharmaceutical Parkinsons Disease Drugs Market Share (2018-2020)
Table Teva Pharmaceutical Main Business
Table Teva Pharmaceutical Recent Development
Table Sun Pharmaceutical Company Profile
Figure Parkinsons Disease Drugs Product Picture and Specifications of Sun Pharmaceutical
Table Parkinsons Disease Drugs Production, Price, Revenue and Gross Margin of 2018-2020
Figure Sun Pharmaceutical Parkinsons Disease Drugs Market Share (2018-2020)
Table Sun Pharmaceutical Main Business
Table Sun Pharmaceutical Recent Development
Table Gilead Sciences Company Profile
Figure Parkinsons Disease Drugs Product Picture and Specifications of Gilead Sciences
Table Parkinsons Disease Drugs Production, Price, Revenue and Gross Margin of 2018-2020
Figure Gilead Sciences Parkinsons Disease Drugs Market Share (2018-2020)
Table Gilead Sciences Main Business
Table Gilead Sciences Recent Development
Table Fudan-Zhangjiang Company Profile
Figure Parkinsons Disease Drugs Product Picture and Specifications of Fudan-Zhangjiang
Table Parkinsons Disease Drugs Production, Price, Revenue and Gross Margin of 2018-2020
Figure Fudan-Zhangjiang Parkinsons Disease Drugs Market Share (2018-2020)
Table Fudan-Zhangjiang Main Business
Table Fudan-Zhangjiang Recent Development
Table Pacira Company Profile
Figure Parkinsons Disease Drugs Product Picture and Specifications of Pacira
Table Parkinsons Disease Drugs Production, Price, Revenue and Gross Margin of 2018-2020
Figure Pacira Parkinsons Disease Drugs Market Share (2018-2020)
Table Pacira Main Business
Table Pacira Recent Development
Table Novartis Company Profile
Figure Parkinsons Disease Drugs Product Picture and Specifications of Novartis
Table Parkinsons Disease Drugs Production, Price, Revenue and Gross Margin of 2018-2020
Figure Novartis Parkinsons Disease Drugs Market Share (2018-2020)
Table Novartis Main Business
Table Novartis Recent Development
Table Sigma-Tau Group Company Profile
Figure Parkinsons Disease Drugs Product Picture and Specifications of Sigma-Tau Group
Table Parkinsons Disease Drugs Production, Price, Revenue and Gross Margin of 2018-2020
Figure Sigma-Tau Group Parkinsons Disease Drugs Market Share (2018-2020)
Table Sigma-Tau Group Main Business
Table Sigma-Tau Group Recent Development
Table Luye Pharma Company Profile
Figure Parkinsons Disease Drugs Product Picture and Specifications of Luye Pharma
Table Parkinsons Disease Drugs Production, Price, Revenue and Gross Margin of 2018-2020
Figure Luye Pharma Parkinsons Disease Drugs Market Share (2018-2020)
Table Luye Pharma Main Business
Table Luye Pharma Recent Development
Table CSPC Company Profile
Figure Parkinsons Disease Drugs Product Picture and Specifications of CSPC
Table Parkinsons Disease Drugs Production, Price, Revenue and Gross Margin of 2018-2020
Figure CSPC Parkinsons Disease Drugs Market Share (2018-2020)
Table CSPC Main Business
Table CSPC Recent Development
Table Kingond Pharm Company Profile
Figure Parkinsons Disease Drugs Product Picture and Specifications of Kingond Pharm
Table Parkinsons Disease Drugs Production, Price, Revenue and Gross Margin of 2018-2020
Figure Kingond Pharm Parkinsons Disease Drugs Market Share (2018-2020)
Table Kingond Pharm Main Business
Table Kingond Pharm Recent Development
Table of Appendix